Sinflorix Vaccines (pneumococcal polysaccharide) suspension


Manufacturer: Belgium



Active immunization of infants and children aged 6 weeks to 5 years for the prevention of pneumococcal infection caused by serotypes of Streptococcus pneumoniae 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive serotype 19A (including sepsis , meningitis, pneumonia, bacteremia and acute otitis media), as well as acute otitis media caused by atypical Haemophilus influenzae.